Biden vs. Trump: What a Difference Two Years Make for Treating COVID

Trouble viewing? View in your browser.
View all Scientific American publications.
    
July 25, 2022

Dear Reader,
 

President Biden revealed that he had COVID last week. But a lot has improved in the roughly two years since former President Trump had the disease, from vaccines to boosters to antiviral treatments. Also this week, how did the monkeypox virus get so many mutations in recent years, and what does it mean for the current outbreak? And, scientists discover a possible biomarker for long COVID.

Tanya Lewis, Senior Editor, Health & Medicine

Health Care

Biden vs. Trump: What a Difference Two Years Make for Treating COVID

Two presidents’ contrasting COVID experiences illustrate the moonshot-caliber medical achievements that let many patients be treated at home instead of in an ICU

By Monique Brouillette

Epidemiology

Why is Monkeypox Evolving So Fast?

The virus circulating in the current outbreak has mutated 50 times in the past four years

By Sara Reardon

Epidemiology

People with Long COVID May Still Have Spike Proteins in Their Blood

Possible biomarker for long COVID suggests some people with the condition never fully cleared the virus

By Sasha Warren

Climate Change

Risk of Dangerous Heat Exposure Is Growing Quickly in Cities

Population growth, climate change and the urban heat island effect are combining to put more people at risk

By Andrea Thompson

Public Health

What Are the Risks of COVID and Treatments Available to President Biden?

An infectious disease doctor explains what Biden’s medical team will be doing to treat the president’s case of COVID

By Patrick Jackson,The Conversation US

Physiology

Scientists Revive Human Retinas after Death

Restoring eye tissue postmortem could pave the way for reviving other types of brain tissue

By Tanya Lewis

Intelligence

If Humans Are the Smartest Animals, Why Are We So Unhappy?

New books on intelligence, medicinal cocktails, galactic history, and more

By Amy Brady

Diabetes

Diabetes Screening Standards in the U.S. Miss the Disease in Many People of Color

Risks for Black, Hispanic and Asian Americans start at lower weights and younger ages than risks for white people

By Claudia Wallis

Policy

Restrictions on Psilocybin 'Magic Mushrooms' Are Easing as Research Ramps Up

Here’s how the psychedelic substance’s legal status has been shifting

By Simon Makin

Genetics

See How Scientists Put Together the Complete Human Genome

For the first time, researchers have sequenced all 3,117,275,501 bases of our genetic code

By Clara Moskowitz,Martin Krzywinski

Reproduction

Police Who Tear-Gas Abortion-Rights Protesters Could Induce Abortion

Tear gas is widely used by law enforcement, even though it may cause spontaneous abortion

By Matthew R. Francis

Medicine

The Hunt for Drugs for Mild COVID

People who are unlikely to develop severe COVID-19 have no widely approved medications to ease the illness

By Saima May Sidik,Nature magazine

Public Health

COVID Virus May Tunnel through Nanotubes from Nose to Brain

Nanotubes may provide a cunning answer to the mystery of how the virus that causes COVID infects neurons and produces long-lasting neurological symptoms

By Stephanie Pappas

QUOTE OF THE DAY

"The differences in both the disease course and treatment for COVID in Trump versus Biden is stark. This shows the incredible benefit of the COVID vaccines, particularly after booster doses, to prevent severe COVID."

Akiko Iwasaki, immunologist at Yale University

FROM THE ARCHIVE

Trump's COVID Infection Puts Him in Multiple High-Risk Categories

The president is age 74, male and heavy—all factors linked to more severe cases of the illness

LATEST ISSUES

Questions?   Comments?

Send Us Your Feedback
Download the Scientific American App
Download on the App Store
Download on Google Play

To view this email as a web page, go here.

You received this email because you opted-in to receive email from Scientific American.

To ensure delivery please add news@email.scientificamerican.com to your address book.

Unsubscribe     Manage Email Preferences     Privacy Policy     Contact Us

Commentaires

Posts les plus consultés de ce blog

Chris Ramsey can take the heat, but what would relegation for QPR mean for black managers in the Premier League?

'Game of Thrones' gave fans of Missandei and Grey Worm something to love tonight